Company intelligence / Profile preview

Affymetrix

Santa Clara, California, United Statesisogg.org ↗

Ownership: Private
Employees: ~1100
Development stage: Commercial

Overview

Affymetrix pioneered DNA microarray technology with its GeneChip® platform. Its products have been cited in over ninety thousand peer-reviewed publications. The company’s tools are industry standards for high-throughput genomic analysis in both research and clinical settings.[6][5] No drug or therapeutic programs—platform/tools only.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Genomic microarrays (DNA microarrays/GeneChips)RNA analysis toolsProtein and cellular analysis platforms[6][3][4]
Industry: Molecular Diagnostics

Partnerships

Collaborated with major pharmaceutical companies and academic/government institutions globally. Specific partnerships not detailed in search results but included broad adoption by pharma/biotech sectors.[5][6]

Beyond the preview

Go deeper on Affymetrix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Affymetrix.

Explore the full profile